关于标准化克罗恩病抗纤维化狭窄治疗的定义、诊断和治疗目标的专家共识
该专家共识由15名胃肠病学家和放射学家组成的跨学科专家组,采用改良RAND/UCLA适宜性方法,对109项候选条目进行匿名评分,旨在标准化克罗恩病纤维化狭窄的定义、诊断和治疗目标。共识明确纤维化狭窄由管腔狭窄、肠壁增厚和狭窄前扩张组合定义,磁共振成像为最佳评估技术,24-48周内需干预被视为药物试验的适当终点。
要点
- 纤维化狭窄定义为管腔狭窄、肠壁增厚和狭窄前扩张的组合。
- 磁共振成像被认为是定义纤维化狭窄和评估治疗反应的最佳技术。
- 24-48周内需内镜下球囊扩张或手术被视为药物试验的适当终点。
核心结论
- 针对狭窄型克罗恩病诊断和治疗反应的共识标准应同时指导临床实践和试验设计。
研究设计与样本
- 由15名胃肠病学家和放射学家组成的跨学科专家组,采用改良RAND/加州大学洛杉矶分校适宜性方法,对源自系统评价和专家意见的109项候选条目进行匿名评分,聚焦小肠狭窄。
主要发现
- 纤维化狭窄由管腔狭窄、肠壁增厚和狭窄前扩张的组合定义。
- 吻合口狭窄(既往肠切除吻合部位)和初发小肠狭窄的定义相似,但吻合口狭窄的肠壁厚度存在不确定性。
- 磁共振成像被认为是定义纤维化狭窄和评估治疗反应的最佳技术。
- 症状性狭窄由腹胀、绞痛、饮食限制、恶心、呕吐、腹痛和餐后腹痛定义。
- 24-48周内需干预(内镜下球囊扩张或手术)被认为是药物试验的适当终点。
关键数值与推荐
- 症状性狭窄的定义包括腹胀、绞痛、饮食限制、恶心、呕吐、腹痛和餐后腹痛。
- 药物试验的适当终点为24-48周内需干预(内镜下球囊扩张或手术)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fibrotic stricture is a common complication of Crohn's disease (CD) affecting approximately half of all patients. No specific anti-fibrotic therapies are available; however, several therapies are currently under evaluation. Drug development for the indication of stricturing CD is hampered by a lack of standardised definitions, diagnostic modalities, clinical trial eligibility criteria, endpoints and treatment targets in stricturing CD. AIM: To standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Chron's disease. METHODS: An interdisciplinary expert panel consisting of 15 gastroenterologists and radiologists was assembled. Using modified RAND/University of California Los Angeles appropriateness methodology, 109 candidate items derived from systematic review and expert opinion focusing on small intestinal strictures were anonymously rated as inappropriate, uncertain or appropriate. Survey results were discussed as a group before a second and third round of voting. RESULTS: Fibrotic strictures are defined by the combination of luminal narrowing, wall thickening and pre-stenotic dilation. Definitions of anastomotic (at site of prior intestinal resection with anastomosis) and naïve small bowel strictures were similar; however, there was uncertainty regarding wall thickness in anastomotic strictures. Magnetic resonance imaging is considered the optimal technique to define fibrotic strictures and assess response to therapy. Symptomatic strictures are defined by abdominal distension, cramping, dietary restrictions, nausea, vomiting, abdominal pain and post-prandial abdominal pain. Need for intervention (endoscopic balloon dilation or surgery) within 24-48 weeks is considered the appropriate endpoint in pharmacological trials. CONCLUSIONS: Consensus criteria for diagnosis and response to therapy in stricturing Crohn's disease should inform both clinical practice and trial design.
引用
- Rieder F, Bettenworth D, Ma C, et al. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease. Aliment Pharmacol Ther. 2018. PMID: 29920726. doi:10.1111/apt.14853
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。